StonvexLoading…
StonvexStonvexStonvexCore line items from GUTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $93.00K | $90.00K | $76.00K |
Operating Income | $-96.82M | $-93.53M | $-68.32M | $-44.53M |
Net Income | $-140.95M | $-68.69M | $-43.72M | $-17.23M |
EPS (Diluted) | $-1.86 | $-1.62 | $-1.09 | $-0.57 |
Total Assets | $121.40M | $108.08M | $126.92M | $146.44M |
Total Liabilities | $111.94M | $79.65M | $76.60M | $75.68M |
Cash & Equivalents | $81.54M | $67.46M | $84.66M | $102.44M |
Free Cash Flow OCF − CapEx | $-90.89M | $-67.29M | $-50.02M | $-31.77M |
Shares Outstanding | 153.37M | 48.76M | 48.09M | 47.91M |